Among the top activated TFs identified by both the M2Kb and the ChIP-Atlas regulons, five TFs (NFYC, RUVBL1, E2F1, HCFC1 and CREB1) have been classified as prognostic markers for lower patient survival in liver cancer ((53) and Figure 3B). Here, E2F1 is linked to liver cancer.